Ischemia and loss of ATP in tumours following treatment with focused high energy shock waves. by Dellian, M. et al.
Br. J. Cancer (1993), 68, 26-31
Macmillan
Ischemia and loss of ATP in tumours following treatment with focused
high energy shock waves
M. Dellian', S. Walenta2, F. Gamarral, G.E.H. Kuhnlel, W. Mueller-Klieser2 & A.E. Goetz3
'Institutefor Surgical Research, 3Institute ofAnesthesiology, Klinikum Grosshadern, Ludwig-Maximiians-University,
Marchioninistr. 15, D-8000 Munich 70; and2'nstitute ofPhysiology andPathophysiology, University ofMainz, Saarstr. 21,
D-6500 Mainz, Germany.
Summary High energy shock waves (HESW) have been reported to be cytotoxic to tumour cells in vitro and
in vivo. For that reason they are evaluated as a new modality for cancer treatment. In the present study we
have quantified the effect of treatment with multifocal HESW on tumour blood flow and energy status. Blood
flow and adenosine triphosphate (ATP) concentration were investigated simultaneously in tumour and
adjacent tissue of six treated and six untreated amelanotic hamster melanomas (A-Mel-3) at 3, 12 or 24 h after
multifocal application of HESW. '4C-iodoantipyrine autoradiography for blood flow measurements and
quantitative ATP imaging bioluminescence were employed. Following treatment, tumour blood flow and ATP
concentration were significantly reduced, as compared to control, over the entire period of observation. Three
hours after HESW, blood flow and ATP concentration were at the background level. In adjacent tissue, blood
flow and ATP concentration were distinctly diminished. We therefore conclude that multifocal HESW induce
a breakdown of tumour-, and adjacent tissue perfusion which is accompanied by a significant decrease of
intracellular ATP concentration.
The clinical introduction of Extracorporeal Shock Wave
Lithotripsy (ESWL) in 1980 has changed the conventional
methods for treatment of renal and ureteric calculi (Chaussy,
1988; Lingeman et al., 1989). Initially, it has been presumed
that ESWL disintegrates calculi without any significant effect
on the surrounding tissues (Chaussy et al., 1982). Subse-
quently, detailed studies on acute and chronic adverse effects
revealed morphologic and functional changes similar to renal
contusion (Ackaert & Schr6der, 1989; Sakamoto et al., 1991;
Smith et al., 1991). Due to these adverse effects on soft tissue
and the potential for noninvasive delivery of focused energy,
the suitability of HESW for treatment of cancer has been
suggested. Several studies have indicated that HESW are
cytotoxic to tumour cells in vitro and in vivo (Russo et al.,
1986; Kohri et al., 1990; Weiss et al., 1990; Clayman et al.,
1991; Kaver et al., 1992). Furthermore, the combination of
HESW with experimental chemotherapy or immunotherapy
results in an enhanced therapeutic efficacy (Oosterhof et al.,
1990a; Gambihler & Delius, 1992). The effects of HESW on
tumours are dependent on the dose of HESW and the mode
of administration (Oosterhof et al., 1990b; Weiss et al.,
1990).
Haemorrhage and destruction of vessels in tumours treated
with HESW have pointed to the tumour vasculature as being
a major target for HESW application (Hoshi et al., 1991).
Reduction of nutritional tumour blood flow may potentially
contribute to the effect of HESW on tumour growth
observed in vivo. Thus, one of the causal factors in the
efficiency of HESW for cancer treatment may be the
preferential susceptibility of the tumour vasculature (Ribbert,
1904; Goetz et al., 1987; Jain, 1988). Observations of the
microvasculature have indicated that ischemia occurs
immediately after application of HESW, which is caused in
part by destruction of the vascular integrity (Brendel et al.,
1987; Goetz et al., 1987; Hoshi et al., 1991). This implies that
exact knowledge about tumour perfusion following applica-
tion of HESW would be of importance for the use of HESW
as an adjuvant for cancer therapy. This is further supported
by the fact that other non-surgical treatment modalities like
radiotherapy, chemotherapy or hyperthermia are critically
dependent on the blood supply of tumours and are also
known to affect tumour blood flow (for a review, see Chap-
lin, 1991).
It has been reported that tumour ischemia of at least 15 h
is required to achieve complete tumour remission (Denekamp
et al., 1983). However, evaluation of blood flow alone does
not yield conclusive information about cellular damage and
viability. In contrast, a decrease of the cellular ATP level
may be considered a sign of severe cellular damage. A heal-
thy cell is dependent on sufficient energy production and a
critical level of ATP. After death organic phosphates are
broken down to inorganic phosphate (Atkinson, 1977). Con-
sequently, measurement of the phosphate status may be used
to provide early information about metabolic disorders
caused by treatment.
The purpose of this investigation was to quantify simul-
taneously the effects of multifocally applied HESW on blood
flow and ATP concentration in solid tumours, and their
adjacent tissue. In order to facilitate interpretation of the
data with respect to the efficiency of this therapeutic app-
roach, tumour growth following HESW application was
examined.
Materials and methods
Animals and tumours
Experiments were performed on amelonotic melanoma A-
Mel-3 tumours (Fortner et at., 1961) implanted into the
depilated back ofmale Syrian Golden Hamsters (9-11 weeks
old, 80-100 g body weight). A total of 5 x 106 cells
suspended in a volume of 10 IA were injected subcutaneously
at a single site for determination of tumour growth or at two
separate sites in the thoracic and lumbar region for
measurements of blood flow and ATP. Animals were anes-
thetised with 60 mg kg-' pentobarbital i.p. (Nembutal®;
Sanofi-LEVA, Hannover, Germany). After 5 days, tumours
had reached a volume of 90-140 mm3. At this size the
tumours were growing exponentially with a mean volume
doubling time of 1.8 days. All hamsters developed tumours,
and no spontaneous regressions occurred.
HESW exposure
HESW were generated by an electrohydraulic lithotripter
(XL1; Dornier Medizintechnik, Gennering, Germany). For
HESW treatment animals were immersed in water in a water-
tight perspex tube. Hamsters were anesthetised as described
above, with the addition of atropine (0.1 mg kg-'). A dorsal
skin flap bearing the tumours was drawn through a small slit
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in the perspex tube. The skin flap was fixed to an external
suspension arch with four sutures. As protection for the
animal's body from the high pressure field, the tube was
covered with 2 mm polystyrene on the inner and outer sides.
The tube was submerged into a warm water bath (33-35°C)
of the lithotripter with the water level 10 cm above the
tumour. The tumour to be treated was randomly chosen and
placed in the high pressure field by positioning it at the
intersection of the two laser beams. The second tumour
served as intraindividual control, at least 2 cm away from the
centre of the HESW focus. Seven hundred HESW were
applied multifocally at a rate of 100 per min with a discharge
voltage of 20 kV and a condenser capacity of 80 nF. Mul-
tifocal application was employed in order to give a more
equal distribution of HESW energy within the tumour tissue
and adjacent tissue. For this purpose 200 HESW were
focused on the tumour centre and another 500 HESW on
five symmetric areas at the tumour border as shown in
Figure 1. Control animals for observation of tumour growth
were placed in the same perspex tube, in the same water
bath, for the same time, but not exposed to HESW.
Autoradiographic measurement ofbloodflow
Tumour blood flow was measured autoradiographically by
the method described by Kety (1960) and Sakurada et al.
(1978) using the tissue uptake of the inert and readily diffusi-
ble compound [4-N-methyl-'4C]-iodoantipyrine (IAP; NEC
712, Du Pont-NEN, Dreieich, Germany).
Animals were anesthetised and polyethylene catheters
(Portex Ltd., Hythe, Kent, England) were inserted into the
right carotid artery, vena cava superior and femoral artery.
Forty pCi of IAP were dissolved in 0.55 ml of 0.9% saline
and infused over 30s at a constant rate via the central
venous catheter. Simultaneously, arterial blood samples for
determination of blood concentration of IAP were collected
every 4 s via the free-flowing catheter in the carotid artery,
which was reduced to 35 mm length to minimise catheter
smearing. Mean arterial blood pressure was registered con-
r
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tinuously via the femoral artery. Thirty seconds after start of
the infusion the tumours and adjacent skin were rapidly
resected and immediately frozen in liquid nitrogen. Blood
samples were weighted and the '4C activity was measured
using a P-Counter (RackBeta 1219, LKB Wallac, Turku,
Finland). The concentration of IAP in each blood sample
was calculated.
Tumours were cut into serial cryosections alternately for
blood flow measurements (thickness: 201tm), histology
(5pm) and ATP measurements (5gm). Sections for his-
tologic observation were stained with hematoxylin and eosin.
Cryosections for ATP-bioluminescence were mounted on
coverslips at - 15°C, heat-inactivated at 90°C for 10 min and
kept at - 80°C until the determination of regional tissue
ATP content described below.
Tissue radioactivity was visualised by exposure of the
tumour sections together with calibrated '4C tissue standards
(14C micro-scales; Amersham Buchler GmbH, Braunschweig,
Germany) to Kodak NMC film (Eastman Kodak, Rochester,
New York, USA) for 2 weeks. The autoradiogram of the
'4C-IAP distribution on the processed film was recorded with
a CCD-videocamera (XC-77; Sony, Cologne, Germany) on a
macro-viewer with transmitted light and digitised (IBAS 2.0;
Kontron GmbH, Eching, Germany). Grey levels of the auto-
radiographic images were measured in 8 sections of each
tumour and adjacent tissue. Regional blood flow was cal-
culated according to Sakurada et al. (1978) with the equation
derived by Kety (1960):
Ci(T) = A x KoJT Ca(t) x e K(T-t) dt (1)
Ci(T) represents the tissue concentration of IAP at time
t = T, the end of 30 s infusion period. A is the tumour-blood
partition coefficient for the A-Mel-3 tumour, which was
determined according to the method of Sakurada et al.
(1978) and found to be 0.86 (Gamarra, 1992). Ca(t) is the
arterial concentration of IAP at time t after the start of
infusion. The specific blood flow F is derived from the
parameter K using the following relationship:
F = K x A (2)
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Figure 1 Scheme ofmultifocal HESW treatment. Two hundred HESW were applied to the tumour centre and 100 HESW each to
five points (crosses) at the edge of tumour nodule (hatched). Tumour diameter was 6-8 mm. Dashed circles indicate the HESW
focal region defined by an isobar representing 50% of maximum HESW pressure, which is 5 mm in diameter and 22 mm in the
longitudinal axis (Muller, 1990).28 M. DELLIAN et al.
These equations were fitted by an iterative polynomial regres-
sion with a computer program integrated into the image
analysis system (IBAS 2.0 Autoradiography Software
Package; Kontron GmbH, Eching, Germany).
Imaging ofATP concentration with bioluminescence
The distribution of ATP concentration within the tumours
was visualised using single photon imaging and quantitative,
specific substrate-induced bioluminescence (Mueller-Klieser
et al., 1988; Walenta et al., 1990). A rectangular casting mold
within a glass slide was filled with a frozen solution contain-
ing all enzymes, coenzymes and cofactors necessary for the
bioluminescence reaction induced by ATP. For measurement,
a frozen tumour section attached to a glass coverslip, is laid
upon the frozen enzyme solution. A luciferase reaction with
light emission occurs immediately after raising the cocktail/
tumour sandwich above the melting point of the cocktail at
10°C. The spatial distribution of the bioluminescence light
emission within the tumour section is recorded directly using
a microscope (Axiophot; Zeiss, Oberkochen, Germany) and
an imaging photon counting system (Argus 100; Hamamatsu,
Herrsching, Germany). The light intensity of the process was
calibrated in absolute terms in mM in relation to tissue
volume using tissue-homogenates of known ATP concentra-
tions, as determined by HPLC. These standards were pro-
cessed in the same way as the tumour sections to assess the
relationship between concentration level and bioluminescence
intensity. Before starting the bioluminescence reaction a
transmission light microscopic image of every tumour section
was recorded with the same optical equipment and stored as
a digitised image together with the image obtained from the
bioluminescence reaction of the same section. Grey levels
were measured in four sections of each tumour and adjacent
tissue and the ATP concentrations calculated.
Evaluation oftumour growth
The longer (1) and shorter (w) perpendicular axes and the
height (h) of each tumour nodule were measured with cal-
lipers. Individual tumour volume was calculated using the
formula C x I x w x h (Tomayko & Reynolds, 1989). C has
been empirically determined as 0.873, assuming a specific
tumour tissue density of 1 g cm-3 (Weiss et al., 1990).
Tumour response to treatment was classified as follows: com-
plete response (the disappearance of all signs of a tumour);
partial response (>50% reduction in the product of the
largest two perpendicular tumour diameters for a minimum
of 7 days); or no change (<50% reduction, or a decrease
>25% in the product of the largest two perpendicular
tumour diameters for a minimum of 5 days (Livingston &
Carter, 1982)).
Experimentalprocedure
Tumour blood flow and ATP concentration were investigated
simultaneously in three groups of animals, each bearing two
tumours in the dorsal skin. One tumour was treated, the
second served as intraindividual untreated control and
reference. Measurements were performed at 3 (six animals),
12 (six animals) or 24h (six animals) after HESW applica-
tion.
Tumour growth was evaluated in two groups of 13 animals
bearing one tumour. Tumour volumes were determined prior
to and after treatment at 2-day intervals over 51 days.
Statistical analysis
Results are represented as median plus/minus standard error
of the median. Nonparametric one-way analysis of variance
and multiple comparison on ranks of several independent
samples were performed using the Kruskal-Wallis test. Single
comparisons of independent samples were executed using the
Wilcoxon matched pairs test and of related samples using the
U test (Theodorsson-Norheim, 1986; 1987). P-values smaller
than 5% were regarded as significant.
Results
Measurement ofbloodflow and ATP concentration
Blood flow and ATP concentration in untreated and treated
tumours and adjacent tissue are given in Table I. Adjacent
normal tissue consisted ofmuscle, subcutaneous fat and skin.
A wide inter-individual heterogeneity of blood flow and ATP
concentration was observed in untreated tumours and un-
treated adjacent tissue. No differences were obtained between
the three groups ofcontrols. Untreated tumours and adjacent
tissue revealed similar blood flow values of 35.8 ml 100 g-'
minm and 34.9 ml 100 g' min' , respectively, whereas ATP
concentration was higher in adjacent tissue (1.50 mM) than in
tumour tissue (1.03 mM). HESW application resulted in a
significant decrease in blood flow in tumours and adjacent
tissue with the lowest values obtained 3 h after treatment. To
illustrate the pattern of flow changes, which was clear despite
intraindividual variability, blood flow in individual untreated
tumours and treated tumours is depicted in Figure 2a. Three
hours after treatment blood flow fell to background level in
the majority of tumours. Values of the perfusion were signifi-
cantly elevated 24 h after treatment (P<0.001). The reduc-
tion of blood flow in adjacent tissue following HESW was
less pronounced (Figure 2b).
ATP concentrations significantly declined in treated
tumours (P<0.001) with minimum values 3 h after therapy
(Figure 3a). Subsequently, ATP concentrations increased
without reaching control levels. Adjacent tissue showed
decreased ATP concentrations at 3, 12 and 24 h after HESW
(Figure 3b). Thus, HESW induced corresponding changes in
blood flow and ATP in both tumour and adjacent normal
tissue. The effects seen were less dramatic in normal tissue as
compared to tumour.
Table I Blood flow and ATP concentration in untreated tumours (control),
treated tumours and the corresponding adjacent normal tissue at 3 (n = 6), 12
(n = 6) and 24 h (n = 6) after application of 700 multifocally focused HESW
Bloodflow ATP
(ml 100g-' min-') (mM)
Adjacent Adjacent
Time Group Tumour tissue Tumour tissue
3 h Control 29.5 ± 15.2 26.1 ± 8.9 0.36 ± 0.36 1.29 ± 0.50
Treated 0.3 0.2 3.2 1.6 0.09 ± 0.16 0.39 ± 0.31
12h Control 36.2± 17.9 46.2± 12.2 0.64±0.40 1.04±0.81
Treated 1.4± 1.8 10.9± 9.8 0.12±0.11 0.44±0.18
24 h Control 47.1 ± 16.2 32.2 9.9 1.20 0.50 1.46 ± 0.76
Treated 4.9 ± 5.5 17.9 ± 8.0 0.28 ± 0.15 0.79 ± 0.92
All controls 35.8 6.7 34.9 5.2 1.03 0.25 1.50 0.19
Data are presented as median ± standard error of the median. Results from
statistical comparisons are given in Figures 2 and 3.ISCHEMIA AND LOSS OF ATP IN TUMOURS FOLLOWING SHOCK WAVES 29
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Figure 2 a, Blood flow 3, 12 and 24 h after HESW in untreated
tumours (open diamonds) and treated tumours (filled diamonds).
Each point represents the median value of blood flow from
measurements in eight sections of one tumour, horizontal lines
indicate median of the group. Groups consisted of six animals,
each bearing two tumours. Three, 12 and 24 h following treat-
ment blood flow was significantly reduced in comparison to
controls ("*P<0.01; *"P<0.001). Treated tumours revealed
lower values 3h (+P<0.05) and 12h (++P<0.01) than 24h
after therapy. b, Blood flow 3, 12 and 24 h after HESW in
adjacent normal tissue of untreated tumours (open diamonds)
and treated tumours (filled diamonds). Blood flow was
significantly reduced in HESW treated normal tissues 3, 12 and
24h after therapy (..P<0.001). Three hours after HESW adja-
cent tissue's blood flow was below values obtained 12 h
(+ P<0.05) or 24 h (+ P<0.01) following therapy.
Evaluation oftumour growth
Exponential tumour growth was observed in all untreated
tumours. Immediately after multifocal application of 700
HESW tumours showed haemorrhage, a decrease in their
volume and softening. Twelve hours later crusts appeared on
the tumour nodule, which healed after 1 week. Treatment
significantly inhibited growth of tumours for 4 days (Figure
4; P<0.001). After this time tumours again resumed
exponential growth. Growth rate slightly increased post-
treatment in comparison to controls. Three of 13 tumours
treated with HESW revealed 'no change' in the product of
the largest two perpendicular tumour diameters for a
minimum of 5 days. No partial or complete tumour response
was observed and no differences were obtained in metastasis
or survival time of the groups.
Discussion
The present study was concerned with the influence of multi-
focally applied HESW on blood flow and ATP concentra-
tions in the A-Mel-3 tumour. Two quantitative high resolu-
tion methods have been combined to examine simultaneously
blood flow and ATP concentrations at different times after
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Figure 3 a, ATP concentrations 3, 12 and 24 h following treat-
ment in untreated tumours (open diamonds) and treated tumours
(filled diamonds). Each point represents the median value of ATP
concentration from measurements in four sections of one tumour,
horizontal lines indicate median of the group. Data were derived
from 18 animals, each bearing two tumours. Three, 12 and 24 h
following HESW ATP concentrations were significantly reduced
("'P<0.001). b, ATP concentrations 3, 12 and 24 h following
HESW treatment in adjacent normal tissue of untreated tumours
(open diamonds) and treated tumours (filled diamonds). ATP
concentrations were significantly reduced 3 h (..P<0.001), 12 h
(*"P<0.01) and 24h ('P<0.05) after application of HESW.
therapy. In addition, the effect of HESW on tumour growth
has been investigated. We observed tumour ischemia and
ATP concentrations reduced to background level 3 h after
HESW therapy. Thereafter, values of both parameters in-
creased. Twenty-four hours following treatment tumour
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Figure 4 Changes in tumour volume of A-Mel-3 tumours with-
out treatment (open circles, n = 13) and following multifocal
application of 700 HESW (filled circles, n = 13). HESW treated
tumours revealed a growth delay of 4 days in comparison to
exponential growth of untreated tumours (median ± s.e.;
***P<0.001, **P<0.01 vs controls).
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blood flow was still reduced to 10% and ATP concentrations
to 23% of controls. Both parameters revealed the same time
course. Similar to blood flow, ATP concentrations were more
diminished in tumour tissue than in adjacent tissue.
Earlier investigations, which have focused on the acute
effects, have proven stasis in tumour microvessels
immediately following HESW therapy (Brendel et al., 1987;
Goetz et al., 1987). We have observed long term effects of
this treatment modality. Results indicate a breakdown of
tumour perfusion for at least 3 h. Twelve hours after therapy,
reperfusion was seen mainly at the periphery of the tumours,
which was continuing at 24 h. The profound, early decrease
of ATP concentrations 3 h after HESW, suggests that
tumour cells were directly affected by HESW. A decrease in
ATP concentrations that is related exclusively to ischemia
would be expected later, as solid tumours can withstand
ischemic periods of up to 15 h (Denekamp et al., 1983).
However, the severe decline of tumour blood flow indicates
that an important part of the observed tumouricidal effect of
HESW may be interpreted as related to vascular damage of
the tumour.
Smits et al. (1991) evaluated the effect of HESW on
tumour metabolism by means of 31p magnetic resonance
spectroscopy (MRS). Although this method suffers from lack
of quantitative information in absolute terms, it provides
data for comparison with our results. After application of
200 or 800 electromagnetically generated HESW at the centre
of a human tumour kidney xenograft Smits et al. observed a
temporary reduction of the NTP/Pi ratio and tissue pH of
the tumour. Electromagnetically generated HESW are con-
sidered to be less effective in cancer treatment than elect-
rohydraulically generated HESW (Clayman et al., 1991).
Nevertheless, the time course of the reduction of the NTP/Pi
ratio following treatment with 800 HESW was similar to the
time course of ATP reduction which we obtained following
application of electrohydraulically generated HESW. This
unexpected finding may be related to a higher sensitivity of
the human tumour kidney xenograft to HESW. In contrast
to the limited spatial resolution of31p MRS, the quantitative
ATP bioluminescence employed in our study yields inform-
ation about the regional distribution of ATP concentration in
tumour and adjacent tissue. In addition regional blood flow
was simultaneously measured. Results indicated that HESW
induce a reduction of ATP concentration and blood flow to a
homogeneously low level within the tumour.
Severe damage to tissue adjacent to the tumour has been
reported in the investigation of Russo et al. (1987), who
applied between 600 and 1500 HESW centrally to Dunning
R3327AT-3 tumours of about 5 mm in diameter implanted
into the thigh of rats. In these morphological studies haemor-
rhage, muscle necrosis, and inflammation were observed in
surrounding tissue. Within the tumours, haemorrhage and
necrotic cells were detected as well, but there was no charac-
teristic pattern of damage. In our study, a larger decrease of
blood flow in tumour tissue in comparison to surrounding
tissue was registered. An enhanced vulnerability of tumour
vasculature as opposed to surrounding tissue has also been
proposed by Goetz et al. (1987), who investigated the effects
of HESW on the A-Mel-3 tumour implanted into a chamber
preparation. These findings may be explained by a higher
sensitivity of the tumour vasculature to physical disturbances
(Ribbert, 1904; Goetz et al., 1987; Chaplin, 1991). Never-
theless with the multifocal application of HESW a slightly
higher dose of HESW has been applied to tumour tissue than
to adjacent normal tissue. Although the determination of the
HESW dose in tissue volumes is unknown, this may in part
account for the moderate effects observed in surrounding
tissue.
In vitro studies on the effects of HESW have suggested that
cavitation and the creation of shear forces and jets in the
immediate extracellular environment are responsible for cell
injury in suspension (Clayman et al., 1991). In vivo these
mechanisms may more likely develop within blood as a fluid
medium (Clayman et al., 1991). Studies on the effects of
HESW in solid tumours in vivo have demonstrated that
poorly perfused tumours have a reduced susceptibility to
HESW (Oosterhof et al., 1990b). This is further evidence for
an ischemia related cell injury as an important mechanism of
the HESW effects on solid tumours. A higher fraction of
perfusion- and diffusion-limited chronically hypoxic cells has
to be expected in poorly vascularised tumours (Kallinowski
et al., 1989). Thus cells from poorly perfused tumours are
probably adapted to the chronic nutrient deficiency and
might for that reason longer withstand acute, ischemia
related hypoxia.
Our results have shown that tumour growth was
significantly delayed even when 700 HESW were multifocally
applied only once, whereas most investigators observed
tumour growth delay following repeatedly treatments on con-
secutive days with high amounts i.e. 500 to 8000 HESW
(Weiss et al., 1990; Hoshi et al., 1991). The slight increase in
volume doubling time of the regrowing tumours may be
caused by an enhanced synthesis rate of the tumour cells
upon reoxygenation (Wilson et al., 1989). Weiss et al. (1990)
have examined the influence of different HESW application
modes on the growth of solid A-Mel-3 and SSK2 tumours in
the hamster and mouse, respectively. They reported a
significant delay in tumour growth when 500 HESW per day
on 4 consecutive days were applied multifocally. Central
application of the same amount of HESW resulted in no or
only a slight effect on tumour growth. Multifocal application
of HESW is considered to be more effective due to a more
uniform distribution of HESW pressures within the tumour
and especially because of the inclusion of the tumour
periphery and surrounding tissue (Weiss et al., 1990). Blood
vessels of the fast growing tumour A-Mel-3 proliferate
mainly in the tumour margin, whereas necrotic, avascular
areas appear in the central part (Endrich et al., 1982). In skin
muscle adjacent to the subcutaneously implanted tumour
infiltrating tumour cells can be observed upon histological
investigations. The focal region of the XLI lithotripter,
which is defined by the isobar representing 50% of maximum
pressure, is known to be 5 mm in diameter and 22 mm in
longitudinal axis (Muller, 1990). Thus only a part of HESW
energy is delivered to the periphery of tumours 6-9 mm in
diameter when HESW are focused on the tumour centre,
which is known to be nutritionally and metabolically de-
prived. This fact could explain that only a slight, if any,
effect of HESW treatment on solid tumours has been
observed by investigators that applied HESW only to the
tumour centre, especially when larger tumours were treated
(Oosterhof et al., 1990b). The advantages of the multifocal
application mode may be of particular importance when
larger tumour volumes are to be treated and higher dosages
of HESW are required. However, the calculation of mode
and dosage of HESW treatment of larger tumours is, as yet,
completely unknown.
We conclude that both direct cytotoxicity and ischemia-
induced cell injury contribute to the effects of HESW to
tumours in vivo. The reduction of tumour blood flow has to
be taken into consideration when HESW are used in further
studies in multi-fraction treatments or as a combined treat-
ment modality. Tumour hypoxia achieved by HESW might
be especially useful for combination with agents which
preferentially impair hypoxic tumour cells. Multifocal ap-
plication of HESW has proven efficient as affecting tumour
periphery and adjacent tissue and will be especially impor-
tant, when larger tumour volumes or poorly demarcated
tumours are to be treated. Less invasive methods for
monitoring tumour blood flow and energy metabolism, such
as magnetic resonance imaging and positron emission tomo-
graphy, will facilitate the evaluation of new treatment
regimes involving HESW.
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